BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Clinical trial NCT06917079 · RECRUITING

Trial details

NCT number: NCT06917079
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer NSCLC PDAC - Pancreatic Ductal Adenocarcinoma CRC (Colorectal Cancer)Metastatic Non-Small Lung Cell Cancer Metastatic Colorectal Cancer (CRC)KRAS G12A KRAS G12C KRAS G12D KRAS G12S KRAS G12V Metastatic Pancreatic Ductal Adenocarcinoma

Start date: 2025-03-31
Primary completion: 2027-08-01
Enrollment: 665

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.